Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in VYGR — Voyager Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to VYGR Full portfolio

Position in VYGR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$318,146
+$13,627 QoQ
Shares Held
90,899
+15.2% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 135 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VYGR Over Time

Shares Held

Position Value (USD)

Derivatives in VYGR

reported options exposure · as of Jun 30, 2026
CallValue
$248,500
CallShares
71,000
PutValue
$51,450
PutShares
14,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. VYGR ranks #192 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in VYGR

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $248,500 71,000
2026-06-30 $51,450 14,700
2026-06-30 $318,146 90,899
2026-03-31 $136,644 35,400
2026-03-31 $304,519 78,891
2025-12-31 $60,915 15,500
2025-12-31 $225,582 57,400
2025-12-31 $256,165 65,182
2025-09-30 $188,201 40,300
2025-09-30 $257,900 55,225
2025-09-30 $75,654 16,200
2025-06-30 $70,597 22,700
2025-06-30 $273,207 87,848
2025-06-30 $37,320 12,000
2025-03-31 $255,534 75,602
2024-12-31 $349,833 61,699
2024-12-31 $212,058 37,400
2024-09-30 $150,930 25,800
2024-09-30 $199,485 34,100
2024-09-30 $196,636 33,613
2024-06-30 $280,805 35,500
2024-06-30 $449,019 56,766
2024-06-30 $161,364 20,400
2024-03-31 $343,539 36,900
2024-03-31 $334,647 35,945
2024-03-31 $228,095 24,500
2023-12-31 $327,472 38,800
2023-12-31 $398,021 47,159
2023-12-31 $146,012 17,300
2023-09-30 $388,639 50,147
2023-09-30 $295,275 38,100
2023-09-30 $450,275 58,100
2023-06-30 $309,150 27,000
2023-06-30 $645,780 56,400
2023-06-30 $765,615 66,866
2023-03-31 $2,480,946 321,783
2023-03-31 $1,218,180 158,000
2023-03-31 $700,068 90,800
2022-12-31 $399,550 65,500
2022-12-31 $848,503 139,099
2022-09-30 $327,376 55,300
2022-09-30 $401,233 67,776
2022-09-30 $1,111,776 187,800
2022-06-30 $418,428 70,800
2022-06-30 $567,082 95,953
2022-06-30 $1,066,755 180,500
2022-03-31 $592,074 77,700
2022-03-31 $2,132,838 279,900
2021-12-31 $488,884 180,400
2021-12-31 $284,821 105,100